Devyser Diagnostics AB (publ) (STO:DVYSR)
63.40
-0.80 (-1.25%)
Aug 14, 2026, 5:20 PM CET
Devyser Diagnostics AB Employees
Devyser Diagnostics AB had 110 employees as of June 30, 2026. The number of employees decreased by 8 or -6.78% compared to the same quarter last year.
Employees
110
Change
-8
Growth
-6.78%
Revenue / Employee
n/a
Profits / Employee
n/a
Market Cap
1.07B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 110 | -8 | -6.78% |
| Mar 31, 2026 | 110 | -10 | -8.33% |
| Dec 31, 2025 | 116 | -5 | -4.13% |
| Sep 30, 2025 | 108 | -11 | -9.24% |
| Jun 30, 2025 | 118 | -9 | -7.09% |
| Mar 31, 2025 | 120 | -4 | -3.23% |
| Dec 31, 2024 | 121 | 3 | 2.54% |
| Sep 30, 2024 | 119 | 8 | 7.21% |
| Jun 30, 2024 | 127 | 21 | 19.81% |
| Mar 31, 2024 | 124 | 22 | 21.57% |
| Dec 31, 2023 | 118 | 26 | 28.26% |
| Sep 30, 2023 | 111 | 24 | 27.59% |
| Jun 30, 2023 | 106 | 37 | 53.62% |
| Mar 31, 2023 | 102 | 11 | 12.09% |
| Dec 31, 2022 | 92 | 45 | 95.74% |
| Sep 30, 2022 | 87 | 40 | 85.11% |
| Jun 30, 2022 | 69 | - | - |
| Mar 31, 2022 | 91 | - | - |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| BICO Group AB | 557 |
| CellaVision AB | 251 |
| Bactiguard Holding AB | 164 |
| Paxman AB | 143 |
| Sedana Medical AB | 117 |
| Mentice AB | 109 |
| C-Rad AB | 98 |
| Q-linea AB | 70 |
Devyser Diagnostics AB News
- 26 days ago - Devyser Diagnostics AB Earnings Call Transcript: Q2 2026 - Transcripts
- 26 days ago - Devyser Diagnostics AB Quarterly report: Q2 2026 - Filings
- 26 days ago - Devyser Diagnostics AB Slides: Q2 2026 - Filings
- 4 weeks ago - Earnings To Watch: Devyser Diagnostics AB (OSTO:DVYSR) Reports Q2 2026 Result - GuruFocus
- 3 months ago - Devyser Diagnostics AB Earnings Call Transcript: Q1 2026 - Transcripts
- 3 months ago - Devyser Diagnostics AB Quarterly report: Q1 2026 - Filings
- 3 months ago - Devyser Diagnostics AB Slides: Q1 2026 - Filings
- 5 months ago - Devyser Diagnostics AB Slides: FY 2026 - Filings